Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24…

By cutting genome analysis from days to minutes, GOAST v4.0 empowers researchers, clinicians, and pharma companies to accelerate precision medicine, cancer research, drug discovery, and national health programs. Delivering GPU-level performance on optimized CPUs at up to 50% lower cost, GOAST makes high-throughput genomics accessible to institutions of all sizes through Lenovo's pay-as-you-go High-Performance Computing (HPC)-as-a-Service model, TruScale. By cutting genome analysis from days…

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24…

By cutting genome analysis from days to minutes, GOAST v4.0 empowers researchers, clinicians, and pharma companies to accelerate precision medicine, cancer research, drug discovery, and national health programs. Delivering GPU-level performance on optimized CPUs at up to 50% lower cost, GOAST makes high-throughput genomics accessible to institutions of all sizes through Lenovo's pay-as-you-go High-Performance Computing (HPC)-as-a-Service model, TruScale. By cutting genome analysis from days…

New YouGov data finds 1 in 3 Brits may be at risk of B12 deficiency - but most…

The nationally representative survey of 2,178 UK adults shows a clear gap between risk, awareness and behaviour: The nationally representative survey of 2,178 UK adults shows a clear gap between risk, awareness and behaviour: Diet is only part of the picture. Even people who eat animal products can be low in B12 because of absorption issues, age-related changes or genetics. For many, abioactive B12 supplement, a form the body can readily use, can help. For some, aliquid bioactive B12...

States of Mind Launches a European Platform for Progressive Mental Health

Many eligible patients lack trusted resources despite strong evidence of therapeutic benefit. States of Mind prepares clients at the pre-treatment stage through evidence-based educational content, peer support, and eligibility checks. Many eligible patients lack trusted resources despite strong evidence of therapeutic benefit. States of Mind prepares clients at the pre-treatment stage through evidence-based educational content, peer support, and eligibility checks. "Our long-term vision...

International Doctors Visit Smartee HQ and Share Insights on Next-Generation…

During an academic session at Smartee HQ, visiting doctors explored the GS mandibular repositioning protocol — a clear-aligner–based approach used in the management of skeletal Class II cases. During an academic session at Smartee HQ, visiting doctors explored the GS mandibular repositioning protocol — a clear-aligner–based approach used in the management of skeletal Class II cases. Dr.Camilla Molinarifrom Italy,described her experience of applying Smartee solutions and the clinical...

Coway's Icon Pro Water Purifier Honored at the 2025 IDEA Design Awards

The award-winning Icon Pro Water Purifier features a full-screen touch LCD display that delivers intuitive and interactive user experiences. This advanced display provides real-time information and allows users to easily control detailed purifier functions – previously difficult to achieve with traditional button-based models. The award-winning Icon Pro Water Purifier features a full-screen touch LCD display that delivers intuitive and interactive user experiences. This advanced display...

Tryngolza ® (olezarsen) approved in the European Union for familial…

Lydia Abad-Franch, MD, MBA, Head of Research, Development, and Medical Affairs (RDMA) and Chief Medical Officer at Sobi, said, "Tryngolza is the next step in our support for the FCS community in Europe. It has a strong safety and efficacy profile, with significant reductions in triglyceride levels and a notable decrease in acute pancreatitis events, which impact morbidity, mortality, and quality of life. This builds on our commitment to FCS that began with Waylivra (volanesorsen), the only…

80,802 Orion Corporation A shares converted into B shares

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE19 SEPTEMBER 2025 at 9.00 EEST 80,802 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 80,802 A shares have been converted into 80,802 B shares. The conversion has been entered into the Trade Register on 19 September 2025.The total number of shares in Orion Corporation is 141,134,278...

Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of…

Idorsia receives approval from Swissmedic for JERAYGO ™(aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral antihypertensive therapy – the first systemic hypertension treatment to target a new pathway in over 30 years.Allschwil, Switzerland – September 19, 2025Idorsia Ltd (SIX: IDIA) announces that Swissmedic has granted marketing authorization for JERAYGO ™(aprocitentan) for the treatment of...

NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through…

Key Takeaways from the NF-κB Inhibitors Market Report Key Takeaways from the NF-κB Inhibitors Market Report Discover which indication is expected to grab the major NF-κB inhibitors market share @NF-κB Inhibitors Market Report Key Factors Driving the NF-κB Inhibitors Market Growing unmet disease burden NF-κB sits at the crossroads of inflammation and tumor biology, so the pathway's involvement across autoimmune, neuroinflammatory and many cancers creates broad clinical...

DBV Technologies Announces Resignation of Board Member

DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced the resignation of Daniel Soland, as a member of its Board of Directors (the “Board”), effective immediately. “On behalf of the Board, DBV’s management team and shareholders, I thank Daniel for his commitment to the Company,” saidMichel de Rosen,Chairman of the Board...

Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and…

For the past two years, these goats have received compassionate treatment with Innocan's LPT-CBD delivered through a single subcutaneous injection every 6–9 weeks. The treatment was observed to significantly reduce their pain, restore their mobility, and allow them to play and socialize with their animal friends — a transformation that speaks to the profound impact of LPT-CBD. Moreover, no adverse events were noticed, even after such a long period of repeated treatment. For the past two…

LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic…

Most recently, Bill served as Vice President and General Manager, Pharma Services with Quest Diagnostics. Prior to that, he was Chief Operating Officer for Interpace Pharma Solutions, Executive Vice President of Precision Medicine and Pharma for Cancer Genetics, and held leadership roles in scientific affairs and biorepository with LabCorp. Most recently, Bill served as Vice President and General Manager, Pharma Services with Quest Diagnostics. Prior to that, he was Chief Operating Officer...

Kuros statement on media inquiry concerning former Board member

Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros statement on media inquiry concerning former Board memberSchlieren (Zurich), Switzerland, September 18, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, has become aware of a possible imminent publication in a Dutch financial media outlet regarding the recent resignation of Albert Arp, a former member of the company’s Board of Directors. Kuros has...

Dark Horse Consulting Group Acquires Converge Consulting

Dark Horse Consulting Group(“DHCG” or “the Group”), a leader in strategic and operational consulting in advanced therapies—specifically the fields of cell and gene therapy (“CGT”) and biotherapeutics—is delighted to announce the acquisition ofConverge Consulting, LLC(Converge). Converge is known for its ability to bridge the gap between sound strategy and reliable execution for biopharmaceutical organizations in the areas of supply chain, manufacturing, commercial launch readiness,...

Medical Device Manufacturing Equipment (by Production) Market worth $27.80…

Browse in-depth TOC on "Medical Device Manufacturing Equipment (by Production) Market" Browse in-depth TOC on "Medical Device Manufacturing Equipment (by Production) Market" 354 - Tables 51 - Figures 348 - Pages By product,Material processing equipment is estimated to account for the largest market share as it is fundamental to shaping, cutting, welding, and assembling medical devices with high precision and reliability. Growing demand for minimally invasive devices,...

Endoscopy Equipment Market worth $53.54 billion by 2030 with 7.6% CAGR |…

Browse in-depth TOC on "Endoscopy Equipment Market"450 - Tables60 - Figures400 - Pages Browse in-depth TOC on "Endoscopy Equipment Market" 450 - Tables 60 - Figures 400 - Pages By product,the endoscopy equipment market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories. The endoscopes segment is further divided into the rigid endoscopes, flexible endoscopes, robot-assisted endoscopes, and capsule endoscopes. In 2024, rigid...

Contract Development and Manufacturing Organization (CDMO) Outsourcing Market…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=890272 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=890272 Browse in-depth TOC on Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 202 – Pages 126 – Tables 37 – Figures Scope of The Report Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Overview Contract Development and...

CeraVe Taps Madeline Argy for Unfiltered Conversations on Acne Breakouts

In a series of digital and social content, this new campaign showcases Madeline's 'crashing out' — defined as becoming suddenly, uncontrollably angry or distressed — over an unwanted breakout, a common experience for acne sufferers. To highlight the benefits of this innovative formula, the content features conversations with board-certified dermatologists who emphasize the importance of not only covering pimples but treating them to prevent both acne marks and future breakouts. In a series of...

Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging…

VANCOUVER, BC, Sept. 18, 2025 /PRNewswire/ -- USA News Group News Commentary –Today, Americans over 65 command $22,356 in annual healthcare spending per person versus just $4,217 for children[1], driving unprecedented investment in longevity solutions as populations worldwide confront global demographics where those aged 60+ will surge from 900 million in 2015 to 2 billion by 2050[2]. These macro forces position Avant Technologies, Inc. (OTCQB: AVAI), HCW Biologics Inc. (NASDAQ: HCWB), Solid…

Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at…

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

KingSmith Celebrates 10 Years of Innovation with Global "One Endless Journey"…

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24…

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24…

New YouGov data finds 1 in 3 Brits may be at risk of B12 deficiency - but most…

States of Mind Launches a European Platform for Progressive Mental Health

International Doctors Visit Smartee HQ and Share Insights on Next-Generation…

Coway's Icon Pro Water Purifier Honored at the 2025 IDEA Design Awards

Tryngolza ® (olezarsen) approved in the European Union for familial…

80,802 Orion Corporation A shares converted into B shares

Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of…

NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through…

DBV Technologies Announces Resignation of Board Member

Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and…

LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic…

Kuros statement on media inquiry concerning former Board member

Dark Horse Consulting Group Acquires Converge Consulting

Medical Device Manufacturing Equipment (by Production) Market worth $27.80…

Endoscopy Equipment Market worth $53.54 billion by 2030 with 7.6% CAGR |…

Contract Development and Manufacturing Organization (CDMO) Outsourcing Market…

CeraVe Taps Madeline Argy for Unfiltered Conversations on Acne Breakouts

Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging…